Company intelligence / Profile preview

China Galaxy International

Hong Kong, Hong Kong, China

Ownership: Private
Employees: ~500
Development stage: Other

Overview

China Galaxy International is a leading financial services provider based in Hong Kong and a wholly-owned subsidiary of China Galaxy Securities Co., Ltd. While the firm is not a biotechnology or pharmaceutical developer, it maintains a significant presence in the healthcare sector through its investment banking, equity research, and asset management divisions. The company provides comprehensive financial services including brokerage, corporate finance, and investment research, with a specialized team dedicated to the analysis and financing of life sciences and healthcare companies in the Greater China region. It plays a crucial role in facilitating capital market transactions, such as IPOs and M&A, for emerging biotech firms.

Industry: Investors

Beyond the preview

Go deeper on China Galaxy International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on China Galaxy International.

Explore the full profile